期刊文献+

绝经妇女经雌三醇治疗后生殖内分泌功能的研究 被引量:2

Study on Reproductive Endocrinological Function in Postmenopausal Women Treated with Estriol
暂未订购
导出
摘要 目的 :研究绝经妇女在使用长效雌三醇治疗 3年后生殖内分泌的功能状况。方法 :用放射免疫分析 (RIA)测定了 136例自然绝经后的妇女 (绝经时间为 1~ 5年 ) ,4 8例绝经后 ,用长效雌三醇作激素替代治疗3年的妇女 ,以及 131例正常育龄妇女卵泡期和黄体期血清的六项生殖激素FSH、LH、PRL、T、E2 、P的水平。结果 :正常育龄妇女无论是卵泡期 ,还是黄体期 ,血清的六项生殖激素FSH、LH、PRL、T、E2 、P的水平与绝经后妇女相比较 ,均有非常显著性差异 (所有p<0 0 1;除了 1例绝经后妇女为泌乳素血症外 )。绝经后妇女在使用长效雌三醇治疗 3年后 ,FSH、LH和PRL的水平都明显降低 ,有非常显著性差异 (p <0 0 0 1)而其中以FSH和LH的降低幅度为最大 ,更年期综合征的临床症状亦随之改善。而E2 、P、T水平变化不大 ,无显著性差异 (p >0 0 5 )。结论 :测定生殖激素水平在中老年妇女的雌激素替代治疗中具有非常重要的意义。 Objective To investigte the reproductive endocrinological function in postmenopausal women treated with ultralente estriol for 3 years. Methods Serum levels of six reproductive hormones (FSH, LH, PRL, T, E 2, P) were measured with RIA in ① 136 normal 1-5yrs post-menopausal women ② 48 post-menopausal women treated with estriol for 3 years ③ 131 healthy women of child-bearing age during follicular and luteal phases. Results Serum levels of the six reproductive hormones in women of child-bearing age at both follicular and luteal phases were significantly different from those in post-menopausal women ( p <0 01, except one post-menopausal subject with hyper-prolactinemia). FSH, LH and PRL levels were significantly decreased ( p <0 01) in post-menopausal women treated with estriol for 3 years (especially marked for FSH and LH), accompanied with amelioration of menopausal syndrome. Changes in E 2, P and T levels were not significant ( p >0 05). Conclusion Serum reproductive hormones assay is important for monitoring hormone replacement therapy in aging women.
出处 《放射免疫学杂志》 CAS 2002年第6期327-330,共4页 Journal of Radioimmanology
关键词 绝经妇女 长效雌三醇 生殖激素 雌激素替代治疗 postmenopausal women, ultralente estriol, reproductive hormone, estrogen replacement therapy
  • 相关文献

参考文献21

  • 1五十岚正雄,徐万祥.FSH 分泌的调节机制[J].国外医学(计划生育分册),1989,8(3):163-164. 被引量:4
  • 2Speroff L. Menopause and houmone replacement therapy. Clinics in Geriatric Medicine 1993;9(1):33
  • 3Steingold KA, Laufer L, Chetkowski RJ. Treatment of glushes with transdermal estradiol administration. Journal of Clinical Endocrinology and Metabolism 1985;61:627
  • 4Smith RP. Modern menopause management. Current Opinion in oostetrics and Gynecology 1994;6:495
  • 5Corson SL. A decade of experience with transdermal estrogen, replacement therapy: Overview of key pharmacologic and clinical findings. International Journal of Fertility 1993;38:79
  • 61996年国际骨质疏松会议简报[J].更年期通讯,1997,(1):6-6.
  • 7Lindstedt G, et al. Low sex hormone-binding globulin concentration as indendent risk factor for development of NIDDM 12-year follow-up of population study of women in gothenburg sweden. Diabetes 1991;40:123
  • 8Peter C, et al. Cardiova scular prolection by oestrogen a calcium antagonist effect . Lancet 1993;341:1264
  • 9Knopp RH. Cardiovascnlar effect of endogenus and exogenous sex hormones wver a women lifetime. Am J Obstet Gynecol (Suppl) 1988;158:1633
  • 10Gever leuven JA, et al. Estrogenic effect of gestodene-or desogestrel-containing oral contraceptives on lipoprptein metabolism. Am J Obstet Gynecol (Suppl) 163(1, part2):1990;358

二级参考文献2

  • 1谢万力.-[J].职业医学,1985,12(3):26-26.
  • 2王挺杰.-[J].中华内科杂志,1987,26(2):95-95.

共引文献3

同被引文献17

  • 1胡晓勇,覃伟武,卢少明,陈坚.雌性激素在女性原发性上尿路结石形成中的作用[J].临床泌尿外科杂志,2005,20(3):178-179. 被引量:4
  • 2宋亦军,林守清.雌激素与女性骨关节炎[J].国外医学(妇产科学分册),2005,32(5):271-273. 被引量:13
  • 3陈荣杰,张本恕.雌激素与帕金森病[J].国际神经病学神经外科学杂志,2005,32(5):458-461. 被引量:1
  • 4孙晓平 徐治鸿.舌感觉异常患者的女性激素改变[J].中华口腔医学杂志,1994,29:125-125.
  • 5全国围绝经期妇女健康调查协作组.绝经年龄及有关因素分析[J].江苏医药,1990,16:242-245.
  • 6Marskinen MR, Puolakka. Hormone replacement therapy lowers plasma Lp (a) concentrations comparison of cyctrandermal and tinreglmens. Arterioscler Thrombvasc Biol. 1996, 16:215.
  • 7李尚为 韩字研.雌三醇阴道给药治疗绝经后妇女生殖道萎缩及老年性阴道炎的临床研究[A]..济南:国际暨第五届全国妇产科学术会议论文汇编[C].,1991.300(8).
  • 8Forabosco A, Criscuol M, Coukos G, et al. Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol, 1992,73 ( 5 ): 570 ~574.
  • 9Heimer Gm. Estriol in the postmenopause. Acta Obstet Gyneocol Sc and Suppl, 1987,139:1 - 23.
  • 10Lobo RA. Benefit and risk of estrogen replacement therapy. Am J Obstet Gynecol, 1995,173 (3): 982 - 9.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部